Evaluation of the Efficacy of MMR Vaccination by Continent between 2011 - 2024

Yemisi Otasanya¹

Section:Research Paper, Product Type: Journal-Paper
Vol.10 , Issue.12 , pp.43-57, Dec-2024

Online published on Dec 31, 2024

Copyright © Yemisi Otasanya . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

Abstract :
Aim: A comparison in the number of measles( Rubella) infection across the six regions of the world namely Americas, Africa, Eastern Mediterranean Region, Southeast Asia, West Pacific Region, and Europe, and the impact of the use of MMR vaccination in combating the Measles virus, so as to identify which continent has the lowest measles occurrence to-date, and what factors contributed to its achievement. Research Design: A secondary research method was adopted using statistics obtained from the United Nations Children Fund (UNICEF) database, from the 6 regions, across 223 countries. Data was also obtained from the World Health Organization provisional measles and rubella data Methodology: The quantitative research methodology was adopted for the study of measles cases and immunization from children between 12 to 23 months old, across 223 countries, through the exploration of numerical patterns over a period of 14 years. The aggregated data from UNICEF allowed for sophisticated data analysis, with visibility into trends of MMR vaccination. Data was analyzed for 1st and 2nd dose of administration on MMR across the targeted countries, to confirm the impact of vaccination, against cases per year.

Key-Words / Index Term :
MMR, UNICEF, AFR, SEAR EUR, EMR, WPR, Measles (Rubella), Quantitative Research Methodology, Quantitative Analysis.

References :
[1] A.A. Rabaan, A.A. Mutair, S. Alhumaid, M. Garout, R.A. Alsubki, F.S. Alshahrani, W.A. Alfouzan, J.H. Alestad, A.E. Alsaleh, M.A. Al-Mozaini, T. Koritala, S. Alotaibi, M.-H. Temsah, A. Akbar, R. Ahmad, Z. Khalid, J. Muhammad, and N. Ahmed. “Updates on Measles Incidence and Eradication: Emphasis on the Immunological Aspects of Measles Infection.” Medicina, Vol 58, Issue 5, pp.680, 2022. doi:https://doi.org/10.3390/medicina58050680.
[2] A. Misin, r.m. Antonello, S. Di Bella, G. Campisciano, N.Zanotta, D.R. Giacobbe, M. Comar, and R. Luzzati. “Measles: An Overview of a Re-Emerging Disease in Children and Immunocompromised Patients. Microorganisms.” National Library of Medicine, Vol 8, Issue 2, pp.276, 2020, doi:https://doi.org/10.3390/microorganisms8020276.
[3] B.G. Masresha, C.S. Wiysonge, K. Reggis Katsande, P.M. O’Connor, E. Lebo, and R.T. Perry. “Tracking Measles and Rubella Elimination Progress—World Health Organization African Region, 2022–2023.” Vaccines, Vol 12, Issue 8, pp.949–949, 2024 doi:https://doi.org/10.3390/vaccines12080949.
[4] C. Stein-Zamir, N. Abramson, L. Sokolov, L. Mor-Shimshi, and H. Shoob. “Case Ascertainment of Measles during a Large Outbreak—Laboratory Compared to Epidemiological Confirmation. Diagnostics,” MPDI, Vol 14 Issue 9, pp.943, 2024 doi:https://doi.org/10.3390/diagnostics14090943.
[5] D. Szinger, T. Berki, I. Drenjan?evi?, S. Samardzic, M. Zeli?, M. Sikora, A. Požgain, A. Markovics, N. Farkas, P. Németh, and K. Böröcz. “Raising Epidemiological Awareness: Assessment of Measles/MMR Susceptibility in Highly Vaccinated Clusters within the Hungarian and Croatian Population—A Sero-Surveillance Analysis.” Vaccines, Vol 12, Issue 5, pp.486, 2024 doi:https://doi.org/10.3390/vaccines12050486.
[6] D. Wang, C.L. John and Y.-H. Chen. “Assessment of using Google Trends for real-time monitoring of infectious disease outbreaks: a measles case study.” Scientific Reports, Vol 14, Issue 1, 2024, doi:https://doi.org/10.1038/s41598-024-60120-8.
[7] F. Branda, M. Giovanetti, C. Romano, D. Benvenuto, A. Ciccozzi, D. Sanna, M. Ciccozzi, and F. Scarpa. Global Measles Surveillance: Trends, Challenges, and Implications for Public Health Interventions. Infectious Disease Reports, Vol 16, Issue 2, pp.367–37, 2024. doi:https://doi.org/10.3390/idr16020028.
[8] N.d. Immunization Data. “WHO Immunization Data portal - Detail Page.” 2024, Available at: https://immunizationdata.who.int/global/wiise-detail-page/measles-reported-cases-and-incidence?CODE=Global&YEAR=.(online)
[9] L. Villani, C. Savoia, F.A.Causio, R. Pastorino, W. Ricciardi, and S. Boccia. “Trend in mandatory vaccination coverage in Italy from 2000 to 2021. A joinpoint Regression Analysis.” European Journal of Public Health, Vol 33, Supplement_2, 2023, doi:https://doi.org/10.1093/eurpub/ckad160.439
[10] M. Rockson Adjei, A. Longsignikuu, I. Saeed Iddris, T. Nang Suuri, B. Asamoah, M. Okoye, J. Vanessa Baafi, C. Kubio, S.-A. Ohene, and M. Peter Grobusch. "Trend of measles-rubella vaccination coverage and impact on measles epidemiology in the Savannah Region, Ghana; 2018-2022: A secondary data analysis.” Vaccine, Vol 42 Issue 8, pp.1910–1917, 2024 doi:https://doi.org/10.1016/j.vaccine.2024.02.024.
[11] M.R.H. Mat Daud, N.A. Yaacob, M.I Ibrahim, and W.A.R. Wan Muhammad, “Five-Year Trend of Measles and Its Associated Factors in Pahang, Malaysia: A Population-Based Study.” International Journal of Environmental Research and Public Health, Vol 19, Issue 13, pp.8017, 2022, doi:https://doi.org/10.3390/ijerph19138017.
[12] Paho. “PAHO issues epidemiological alert for measles cases in the Americas”. Paho.org
[13] P. Berche, “History of Measles.” La Presse Médicale. Vol 51 Issue 3, pp.104149, 2022, doi:https://doi.org/10.1016/j.lpm.2022.104149.
[14] R. Wang, W. Jing, M. Liu, and J. Liu. “Trends of the Global, Regional, and National Incidence of Measles, Vaccine Coverage, and Risk Factors in 204 Countries From 1990 to 2019.” Frontiers in Medicine, Vol 8. 2022, doi:https://doi.org/10.3389/fmed.2021.798031.
[15] R.D. de Vries, W.P. Duprex, R.L. de Swart. “Morbillivirus infections: an introduction.” PubMed, Issue 7, pp 699–706, 2015 doi: 10.3390/v7020699. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
[16] S.F. Tefera, N. Admasu, H. Abebe, G.C. Feyisa, and G. Midaksa. “Measles outbreak investigation in Tocha district, southwestern Ethiopia: an unmatched case-control study.” Frontiers in Public Health, Vol 12, pp.1331798. 2024 doi:https://doi.org/10.3389/fpubh.2024.1331798.
[17] Unicef. “Vaccination and immunization statistics - UNICEF data.” UNICEF DATA. 2024,